SUPERNUS PHARMACEUTICALS, INC. Increase (Decrease) in Other Noncurrent Liabilities
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Increase (Decrease) in Other Noncurrent Liabilities of -$3.49 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2020-11-06
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-09-30 was -$758.00K.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-06-30 was -$1.71M, a 598.83% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-03-31 was -$1.02M.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2019-12-31 was -$3.19M, a 529.82% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2019 was -$5.09M, a 712.27% decline from fiscal 2018.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2018 was $831.00K, a 87.24% decline from fiscal 2017.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2017 was $6.51M.
- SUPERNUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2016 was -$334.00K, a 168.30% decline from fiscal 2015.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$758.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$2.47M derived: sum of 2 quarters · filed 2020-11-06 | -$3.49M 10-Q · filed 2020-11-06 | -$6.67M derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-17 | -$2.73M 10-Q · filed 2020-08-17 | -$5.92M derived: sum of 3 quarters · filed 2020-08-17 | -$7.06M derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-03-31 | -$1.02M 10-Q · filed 2020-05-15 | -$4.21M derived: sum of 2 quarters · filed 2020-05-15 | -$5.35M derived: sum of 3 quarters · filed 2020-11-06 | -$5.01M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-12-31 | -$3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$4.33M derived: sum of 2 quarters · filed 2020-11-06 | -$3.99M derived: sum of 3 quarters · filed 2020-11-06 | -$5.09M 10-K · filed 2020-02-28 |
| 2019-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$805.00K derived: sum of 2 quarters · filed 2020-11-06 | -$1.90M 10-Q · filed 2020-11-06 | -$1.16M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $343.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-17 | -$755.00K 10-Q · filed 2020-08-17 | -$14.00K derived: sum of 3 quarters · filed 2020-08-17 | -$1.80M derived: sum of 4 quarters · filed 2020-08-17 |
| 2019-03-31 | -$1.10M 10-Q · filed 2020-05-15 | -$357.00K derived: sum of 2 quarters · filed 2020-05-15 | -$2.14M derived: sum of 3 quarters · filed 2020-05-15 | -$1.25M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $741.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$1.04M derived: sum of 2 quarters · filed 2020-02-28 | -$153.00K derived: sum of 3 quarters · filed 2020-02-28 | $831.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$894.00K derived: sum of 2 quarters · filed 2019-11-08 | $90.00K 10-Q · filed 2019-11-08 | $5.71M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $889.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.87M 10-Q · filed 2019-08-09 | $7.49M derived: sum of 3 quarters · filed 2020-02-28 | $7.91M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $984.00K 10-Q · filed 2019-05-10 | $6.60M derived: sum of 2 quarters · filed 2020-02-28 | $7.02M derived: sum of 3 quarters · filed 2020-02-28 | $7.58M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $6.04M derived: sum of 2 quarters · filed 2020-02-28 | $6.60M derived: sum of 3 quarters · filed 2020-02-28 | $6.51M 10-K · filed 2020-02-28 |
| 2017-09-30 | $417.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $980.00K derived: sum of 2 quarters · filed 2018-11-09 | $894.00K 10-Q · filed 2018-11-09 | $700.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $563.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $477.00K 10-Q · filed 2018-08-09 | $283.00K derived: sum of 3 quarters · filed 2019-03-01 | $147.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$86.00K 10-Q · filed 2018-05-10 | -$280.00K derived: sum of 2 quarters · filed 2019-03-01 | -$416.00K derived: sum of 3 quarters · filed 2019-03-01 | -$493.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$330.00K derived: sum of 2 quarters · filed 2019-03-01 | -$407.00K derived: sum of 3 quarters · filed 2019-03-01 | -$334.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | -$136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$213.00K derived: sum of 2 quarters · filed 2017-11-09 | -$140.00K 10-Q · filed 2017-11-09 | $370.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$4.00K 10-Q · filed 2017-08-03 | $506.00K derived: sum of 3 quarters · filed 2018-03-01 | $967.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $73.00K 10-Q · filed 2017-05-09 | $583.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.04M derived: sum of 3 quarters · filed 2018-03-01 | $1.84M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $510.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $971.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.77M derived: sum of 3 quarters · filed 2018-03-01 | $489.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | $461.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-01-20 | $1.26M derived: sum of 2 quarters · filed 2017-01-23 | -$21.00K 10-Q/A · filed 2017-01-20 | $840.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $795.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-01-23 | -$482.00K 10-Q/A · filed 2017-01-23 | $379.00K derived: sum of 3 quarters · filed 2017-03-16 | $609.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$1.28M 10-Q/A · filed 2017-01-20 | -$416.00K derived: sum of 2 quarters · filed 2017-03-16 | -$186.00K derived: sum of 3 quarters · filed 2017-03-16 | $497.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $861.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $1.09M derived: sum of 2 quarters · filed 2017-03-16 | $1.77M derived: sum of 3 quarters · filed 2017-03-16 | $1.20M 10-K · filed 2017-03-16 |
| 2014-09-30 | $230.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | $913.00K derived: sum of 2 quarters · filed 2017-01-20 | $337.00K 10-Q/A · filed 2017-01-20 | $301.00K derived: sum of 4 quarters · filed 2017-01-20 |
| 2014-06-30 | $683.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $107.00K 10-Q · filed 2015-08-07 | $71.00K derived: sum of 3 quarters · filed 2017-01-20 | $58.00K derived: sum of 4 quarters · filed 2017-01-20 |
| 2014-03-31 | -$576.00K 10-Q · filed 2015-05-06 | -$612.00K derived: sum of 2 quarters · filed 2017-01-20 | -$625.00K derived: sum of 3 quarters · filed 2017-01-20 | -$191.00K derived: sum of 4 quarters · filed 2017-01-20 |
| 2013-12-31 | -$36.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | -$49.00K derived: sum of 2 quarters · filed 2017-01-20 | $385.00K derived: sum of 3 quarters · filed 2017-01-20 | $429.00K 10-K/A · filed 2017-01-20 |
| 2013-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $421.00K derived: sum of 2 quarters · filed 2014-11-12 | $465.00K 10-Q · filed 2014-11-12 | $416.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $478.00K 10-Q · filed 2014-08-12 | $429.00K derived: sum of 3 quarters · filed 2015-03-12 | $554.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $44.00K 10-Q · filed 2014-05-13 | -$5.00K derived: sum of 2 quarters · filed 2015-03-12 | $120.00K derived: sum of 3 quarters · filed 2015-03-12 | $170.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $76.00K derived: sum of 2 quarters · filed 2015-03-12 | $126.00K derived: sum of 3 quarters · filed 2015-03-12 | $109.00K 10-K · filed 2015-03-12 |
| 2012-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $175.00K derived: sum of 2 quarters · filed 2013-11-13 | $158.00K 10-Q · filed 2013-11-13 | $144.00K derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $33.00K 10-Q · filed 2013-08-14 | $19.00K derived: sum of 3 quarters · filed 2014-03-21 | $27.00K derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | -$17.00K 10-Q · filed 2013-05-15 | -$31.00K derived: sum of 2 quarters · filed 2014-03-21 | -$23.00K derived: sum of 3 quarters · filed 2014-03-21 | $136.00K derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$6.00K derived: sum of 2 quarters · filed 2014-03-21 | $153.00K derived: sum of 3 quarters · filed 2014-03-21 | $539.00K 10-K · filed 2014-03-21 |
| 2011-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $167.00K derived: sum of 2 quarters · filed 2012-11-02 | $553.00K 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $545.00K 10-Q · filed 2012-08-13 | ||
| 2011-03-31 | $386.00K 10-Q · filed 2012-06-08 | |||
| 2010-12-31 | $64.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |